• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Plasminogen activator inhibitor 1 and atherothrombosis.

作者信息

Juhan-Vague I, Alessi M C

机构信息

Laboratory of Hematology, University Hospital Timone, Marseille, France.

出版信息

Thromb Haemost. 1993 Jul 1;70(1):138-43.

PMID:8236090
Abstract
摘要

相似文献

1
Plasminogen activator inhibitor 1 and atherothrombosis.
Thromb Haemost. 1993 Jul 1;70(1):138-43.
2
Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissue.
Thromb Haemost. 1999 Aug;82(2):832-6.
3
Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.糖尿病患者纤溶功能减退及其对糖尿病血管疾病的影响。
J Cardiovasc Risk. 1997 Apr;4(2):91-9.
4
Plasminogen-activator inhibitor type 1 and coronary artery disease.1型纤溶酶原激活物抑制剂与冠状动脉疾病
N Engl J Med. 2000 Jun 15;342(24):1792-801. doi: 10.1056/NEJM200006153422406.
5
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.低纤溶活性和纤溶酶原激活物抑制物-1（PAI-1）增加通过胰岛素抵抗和肥胖与动脉粥样硬化血栓形成相关联。
Ann Med. 2000 Dec;32 Suppl 1:78-84.
6
Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease.纤溶酶原激活物抑制剂-1：心血管疾病的一个共同因素
J Investig Med. 1998 Oct;46(8):370-6.
7
Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.胰岛素抵抗导致多囊卵巢综合征年轻女性血管舒张功能受损和纤维蛋白溶解功能减退。
Thromb Res. 2005;116(3):207-14. doi: 10.1016/j.thromres.2004.11.026. Epub 2005 Jan 1.
8
PAI-1, obesity, insulin resistance and risk of cardiovascular events.纤溶酶原激活物抑制剂-1、肥胖、胰岛素抵抗与心血管事件风险
Thromb Haemost. 1997 Jul;78(1):656-60.
9
Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy.缺血性心肌病中的1型纤溶酶原激活物抑制剂
Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1378-86. doi: 10.1161/01.atv.19.6.1378.
10
Physical fitness and the relationship between hypertension and markers of atherothrombosis.身体健康以及高血压与动脉粥样硬化血栓形成标志物之间的关系。
Am J Hypertens. 2007 Jun;20(6):676-7. doi: 10.1016/j.amjhyper.2007.02.003.

引用本文的文献

1
Acute exercise-induced inflammatory and thrombotic response in hypertensive patients.高血压患者急性运动诱发的炎症和血栓形成反应
Eur J Appl Physiol. 2025 Feb;125(2):339-351. doi: 10.1007/s00421-024-05599-9. Epub 2024 Sep 9.
2
Correlations between the Changing Levels of Tissue Plasminogen Activator and Adiposity Following Exercise-Induced Weight Loss.运动诱导体重减轻后组织型纤溶酶原激活物水平变化与肥胖的相关性。
Nutrients. 2022 Dec 4;14(23):5159. doi: 10.3390/nu14235159.
3
Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort.
细胞因子与糖尿病进展的相关性估计：基于社区队列的 10 年随访。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e381-9. doi: 10.1210/clinem/dgz171.
4
Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease.成瘾性冠状动脉疾病患者的血清1型纤溶酶原激活物抑制剂水平。
Addict Health. 2014 Summer-Autumn;6(3-4):119-26.
5
Interleukin-6 -634 C/G and -174 G/C polymorphisms in Korean patients undergoing hemodialysis.白介素-6-634 C/G 和 -174 G/C 多态性与韩国血液透析患者。
Korean J Intern Med. 2012 Sep;27(3):327-37. doi: 10.3904/kjim.2012.27.3.327. Epub 2012 Sep 1.
6
A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia.再生障碍性贫血患者血小板输注后迟发支架内血栓形成 1 例
Korean Circ J. 2012 Jan;42(1):54-7. doi: 10.4070/kcj.2012.42.1.54. Epub 2012 Jan 31.
7
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.马来西亚人群中纤溶酶原激活物抑制剂-1 和组织型纤溶酶原激活物与 2 型糖尿病及代谢综合征的相关性。
Cardiovasc Diabetol. 2011 Mar 18;10:23. doi: 10.1186/1475-2840-10-23.
8
Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.瘦素可上调人血管内皮细胞纤溶酶原激活物抑制剂-1 的表达。
Biochem Biophys Res Commun. 2010 Jan 29;392(1):47-52. doi: 10.1016/j.bbrc.2009.12.158. Epub 2010 Jan 5.
9
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.冠状动脉疾病和2型糖尿病患者的止血危险因素——243例患者的两年随访
Cardiovasc Diabetol. 2009 Sep 7;8:48. doi: 10.1186/1475-2840-8-48.
10
Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.2型糖尿病患者止血危险因素与冠状动脉形态的相关性
Cardiovasc Diabetol. 2009 May 6;8:24. doi: 10.1186/1475-2840-8-24.